Search

This is part two of a summary of a Basser Center panel on the ins and outs of dating with a BRCA mutation.

This is part three of a summary of a Basser Center panel on the ins and outs of dating with a BRCA mutation.

In the first in an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.
 

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses early screening recommendations for young women with BRCA mutations, particularly in terms of breast cancer.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses typical guidelines for follow up to a potential recurrence of BRCA-related breast cancer.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses BRCA-related ovarian cancer risk and management options, such as recent research into fallopian tube removal.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses how BRCA mutations impact men, including which cancers they are at hereditary risk for and recommendations for screening.
 

Basser Center Executive Director Susan Domchek, MD, discusses the BFOR Study and the importance of genetic testing for hereditary cancer in the Ashkenazi Jewish community.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses the differences between BRCA1 and BRCA2 mutations and explains how the varying risk factors could impact individuals and their families.

Basser Young Leadership Council member Jourdan Cohen, a digital marketer and BRCA mutation carrier, shares some advice about things you should bring to the hospital to prepare for preventative surgery.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses hereditary cancer risk for BRCA mutation carriers and ways in which that might impact individuals differently.
 

We share the story of Penn Medicine and Basser Center patient Carlette, a BRCA mutation carrier facing a battle with hereditary breast cancer.

The Seventh Annual Basser Center Scientific Symposium featured Keynote speaker and Basser Global Prize awardee Maria Jasin, PhD, from Memorial Sloan Kettering Cancer Center. Dr. Jasin spoke with us about recent BRCA-related research.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses lifestyle interventions, such as diet and exercise, to reduce hereditary cancer risk.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses alcohol and how it relates to cancer risk.